Results 131 to 140 of about 18,186 (211)

Acquisition of amantadine resistance via M gene reassortment in canine H3N2 influenza virus and elucidation of the resistance mechanism. [PDF]

Virol J
Ga E, Bae E, Xie X, Hwang J, Yeom M, Lim JW, Song D, Na W.   +7 more
europepmc   +1 more source

Modulating glutamate neurotransmission in <i>in vivo</i> models of Multiple Sclerosis: a narrative review. [PDF]

Front Immunol
Stamoula E, Vavilis T, Boskou I, Vampertzi O, Floropoulou N, Demopoulos A, Grigoriou R, Melnikov M.   +7 more
europepmc   +1 more source

Recurrent Catatonia in the Setting of Urinary Tract Infection and Medical Comorbidity: A Case Report. [PDF]

Cureus
Traugott P, Mimbella R, Irizarry Flores JC, Kyomen HH.   +3 more
europepmc   +1 more source

Pharmacon: A Molecular Dynamics Simulation Analysis Toolkit. [PDF]

J Chem Inf Model
Georgiou K, Kolocouris A.
europepmc   +1 more source

The importance of longitudinal evaluation using DAT-SPECT in organophosphate-induced toxic parkinsonism. [PDF]

PCN Rep
Nakao S, Kogoh Y, Funahashi H, Yanoma Y, Azuma M, Ishida Y, Hirano Y.   +6 more
europepmc   +1 more source

Adamantane-based inhibitors of the influenza A M2 proton channel: structure-based design, biological evaluation, and synthetic approaches. [PDF]

RSC Med Chem
Stampolaki M, Kouridaki ME, Georgiou K, Kolocouris A.   +3 more
europepmc   +1 more source

Development of an LC-MS/MS method for amantadine detection in human plasma using ZIF-8 as adsorbent and pharmacokinetic investigation. [PDF]

Front Pharmacol
Wang Z, Han H, Li H, Xu W, Ding K.
europepmc   +1 more source

Frequency and types of motor fluctuations in patients presenting with advanced Parkinson's disease. [PDF]

Pak J Med Sci
Samiksha, Qamar-Un-Nisa, Irfan M, Jawaid W, Rafat Umer S, Jazil Faruqi S.   +5 more
europepmc   +1 more source